Serum concentrations of vascular endothelial growth factor in angiosarcomas with and without p53 gene mutation

Acta Derm Venereol. 2002;82(5):373-4. doi: 10.1080/000155502320624122.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / analysis*
  • Case-Control Studies
  • Endothelial Growth Factors / blood*
  • Endothelial Growth Factors / metabolism
  • Female
  • Genes, p53 / genetics*
  • Hemangiosarcoma / blood
  • Hemangiosarcoma / genetics*
  • Hemangiosarcoma / physiopathology*
  • Humans
  • Intercellular Signaling Peptides and Proteins / blood*
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Lymphokines / blood*
  • Lymphokines / metabolism
  • Male
  • Middle Aged
  • Mutation*
  • Point Mutation
  • Prognosis
  • Prospective Studies
  • Reference Values
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Skin Neoplasms / blood
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / physiopathology*
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Biomarkers, Tumor
  • Endothelial Growth Factors
  • Intercellular Signaling Peptides and Proteins
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors